92-86
FINALPhiladelphia
76ers
42-46|L10: 2-8
Cleveland
Cavaliers
52-42|L10: 5-5
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Cleveland Cavaliers
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 65-16 | 0.802 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 12/14 | L 99-109 | |
| 12/12 |
| 58-23 |
| 0.716 |
| 7.0 |
| 3 | 52-30 | 0.634 | 13.5 |
| 4 | 45-36 | 0.556 | 20.0 |
| 5 | 43-39 | 0.524 | 22.5 |
| 6 | 41-40 | 0.506 | 24.0 |
| 7 | 117-120 | 0.494 | 26.0 |
| 8 | 40-42 | 0.488 | 25.5 |
| 9 | 37-44 | 0.457 | 28.0 |
| 10 | 36-46 | 0.439 | 29.5 |
| 11 | 33-49 | 0.402 | 32.5 |
| 12 | 26-56 | 0.317 | 39.5 |
| 13 | 22-59 | 0.272 | 43.0 |
| 14 | 15-66 | 0.185 | 50.0 |
| 15 | 0-0 | 0.000 | 24.5 |
| 12/10 | W 100-88 |
| 12/8 | W 105-77 |
| 12/7 | W 101-90 |
| Opponent | Date | Result |
|---|---|---|
| 12/14 | L 97-105 | |
| 12/11 | W 118-105 | |
| 12/8 | L 93-96 | |
| 12/5 | L 86-105 | |
| 12/4 | L 79-100 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 19.4 | 45.0% | 29.9% | 70.3% | |
| 16.9 | 49.6% | 2.8% | 64.6% | |
| 12.2 | 44.0% | 23.8% | 53.5% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 29.8 |
| 26.4% |
| 71.8% |
| 13.8 | 46.1% | 0.0% | 65.5% |
| 12.7 | 35.6% | 26.1% | 42.6% |
| Category | CLE Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #2381.0 ORtg | #11104.9 DRtg | PHI |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #811.1% | #116.3% | CLE |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1835.4% | #1235.9% | PHI |
| Category | CLE Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #6103.6 DRtg | #2580.7 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #2013.9% | #1011.3% | PHI |
3P% vs AllowedPerimeter defense vs perimeter shooting | #534.6% | #2831.5% | PHI |
